Home Healthcare Market Report 2025-2030: Increasing Demand for Personalized, Disease-Focused Care

The Home Healthcare Market Research Report 2025‑2030 has been added to ResearchAndMarkets.com's offering. The Home Healthcare Market is projected to grow from USD 351.51 billion in 2024 to USD 513.10 billion by 2030, at a CAGR of 6.51%.

Key takeaways
- The services segment captured over 74% of the market share in 2024.
- Skilled nursing services led the service category in 2024.
- The therapeutic devices segment is seeing rapid growth with a CAGR of 7.36% forecasted.
- Cardiovascular disease accounted for the highest market share by indication in 2024.
- North America represents approximately 40% of the global home healthcare market.
- The market's growth is powered by the integration of remote care services and the rising demand for disease-focused home healthcare.

Home Healthcare Market Trends & Drivers
- Technologies such as AI, IoMT, and homecare analytics are reshaping home healthcare, leading to more engaged and efficient care.
- Continuous Glucose Monitoring and other IoT medical devices are making care more proactive and personalized.
- Technology and software integration facilitate service customization, meeting changing patient demands and enhancing medical professional coordination.
- Custom home care plans tailored from comprehensive health assessments are growing in popularity.
- Telehealth and remote monitoring gained traction during the pandemic, and remote care services such as “Hospital at Home” are becoming mainstream.
- The shift to on-demand, personalized healthcare continues, with apps now providing home delivery of pharmaceuticals and other customized services.

Home Healthcare Market Segmentation Insights
- In 2024, the services segment dominated the market, with skilled nursing services leading the charge.
- Therapeutic devices saw significant growth, driven by dialysis and IV equipment.
- Cardiovascular disease dominated the market due to rising incidence rates and demand for home-based care.

Geographical Analysis
- North America leads the home healthcare market, driven by the prevalence of chronic diseases and an aging population, with the U.S. at the forefront.
- The APAC region is experiencing rapid growth, largely in response to a significant aging population and rising chronic disease cases in countries like China, Japan, and India.

Competitive Landscape
The global home healthcare market features major players like Abbott, GE Healthcare, and Medtronic leading the charge with innovative solutions compliant with regulatory standards. Continuous product development and strategic partnerships are hallmarks of the competitive strategies employed by vendors.

Key Vendors
- Abbott
- GE Healthcare
- Medtronic
- Bayada Home Healthcare
- Cardinal Health

Other Prominent Vendors
- BrightSpring Health Services
- DispatchHealth
- NOVA LEAP HEALTH CORP
- UNITEDHEALTH GROUP

Home Healthcare Market News
- BrightSpring Health Services plans to expand its home care service lines, including rehab, infusion, and home-based primary care by June 2025.
- DispatchHealth and Medically announced their merger in June 2025, aiming to enhance precision home care.
- Emcara Health was acquired by Lucet to meet the growing demand for an integrated care model in June 2025.
- Nova Leap Health completed a significant acquisition in Nova Scotia in 2024.
- UnitedHealth Group's 2023 acquisition of LHC Group marked a major expansion in the home healthcare sector.

Segmentation & Forecast
- By Product: Services, Devices
- By Indication: Cardiovascular, Orthopedic, Metabolic Diseases
- By Geography: North America, Europe, APAC, Latin America, Middle East & Africa

Key Questions Answered
1. What is the growth rate of the global home healthcare market? 2. How big is the global home healthcare market? 3. What are the factors driving the market? 4. Which product type will dominate growth? 5. Who are the major players in the market? 6. Which region will experience the highest growth?

Report Attribute
- No. of Pages: 162
- Forecast Period: 2024‑2030
- Estimated Market Value (USD) in 2024: $351.51 Billion
- Forecasted Market Value (USD) by 2030: $513.10 Billion
- Compound Annual Growth Rate: 6.5%
- Regions Covered: Global

The companies mentioned in this Home Healthcare market report include: Abbott, Air Liquide, A&D Company, Amedisys, B. Braun SE, Bayada Home Healthcare, Cardinal Health, Enhabit Home Health & Hospice, GE Healthcare, Fresenius SE & Co. KGaA, F. Hoffmann La Roche, Koninklijke Philips, Lifepoint Health, Medtronic, Omron Corporation, advita Pflegedienst, Angiplast, Baxter, BrightSpring Health Services, Contec Medical Systems, Drägerwerk, DispatchHealth, EPSIMED, Guangdong Biolight Meditech, Healthcare at Home, Healthline Medical Products, Lucet, LHC Group, Medical Components, Merit Medical Systems, Mitra Industries, MEDIANA, NIHON KOHDEN CORPORATION, Newsol Technologies, Nova Leap Health Corp, OSI Systems, Polymedicure, Privatassistenza, Portea Medical, Renax Biomedical Tech, Skanray Technologies, SCHILLER, Shenzhen Mindray Bio-Medical Electronics, Utah Medical Products, UNITEDHEALTH GROUP.

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Home Healthcare Market Report 2025-2030: Increasing Demand for Personalized, Disease-Focused Care

ResearchAndMarkets.com released its Home Healthcare Market Research Report 2025‑2030, projecting the market to grow from USD 351.51 billion in 2024 to USD 513.10 billion by 2030 (CAGR 6.51%). The services segment dominated in 2024, led by skilled nursing, while therapeutic devices grew at 7.36% CAGR. Cardiovascular disease was the top indication. North America accounts for about 40% of the global market, with APAC showing rapid growth due to aging populations. The report highlights the role of IoMT, AI, and remote care technologies in driving personalized, disease‑focused home healthcare. Key vendors include Abbott, GE Healthcare, Medtronic, Bayada Home Healthcare, Cardinal Health, BrightSpring Health Services, DispatchHealth, Emcara Health, Lucet, Nova Leap Health, UnitedHealth Group, and LHC Group.